 |
A newsletter for those involved in clinical trials. Published 20 times a
year by Canary LtdPlacebo in trials
The following articles on this topic have been published in
CRAdvisor (CRA) – the year, issue number
and starting page number for each are listed below:
Back to index |
| 2005 |
|
|
CRA 2005; 161:7 |
Avoiding failure in Phase III. |
| |
|
| 2004 |
|
| CRA 2004; 136:9 |
Recruitment can be a major ethical problem in the less developed
world. |
| |
|
| 2003 |
|
| CRA 2003; 102:1 |
WHO updates international ethical guidelines for clinical studies. |
| CRA 2003; 104:6 |
Ethical use of placebo. |
| CRA 2003; 114:5 |
Will a new Declaration of Helsinki solve the debate on
placebo-controlled trials? |
| CRA 2003; 117:1 |
Lawsuits issued to investigators, study co-ordinator ,hospital,
sponsor and IRB. |
| |
|
| 2002 |
|
| CRA 2002; 82:1 |
Will Helsinki be revised in 2002? |
| CRA 2002; 90:4 |
Declaration of Helsinki - which version? |
| CRA 2002; 100:6 |
World Medical Association's Declaration of Helsinki. |
| CRA 2002;100:12 |
Overview of documents produced by the ICH process. |
| |
|
| 2001 |
|
| CRA 2001; 66:6 |
Sponsors react to FDA sham controls. |
| CRA 2001; 68:3 |
Special report from Pretoria 2001 - interpreting and implementing
Helsinki 2000. |
| CRA 2001; 71:1 |
WMA may be forced to change Helsinki 2000. |
| CRA 2001; 73:1 |
EMEA releases opinion on placebo trials. |
| CRA 2001; 73:4 |
EMEA/CPMP position statement on the use of placebo in clinical trials
with regard to the revised Declaration of Helsinki. |
| CRA 2001; 79:1 |
WMA clarifies Helsinki placebo problem. |
| |
|
| 2000 |
|
| CRA 2000; 56:1 |
New Declaration of Helsinki approved. |
| CRA 2000; 57:3 |
Use of placebo still major cause of ethical unrest. |
| |
|
| 1998 |
|
| CRA 1998; 3:1 |
Justifying the use of placebo: regulations versus ethics. |
| CRA 1998: 3:3 |
Ethical principles and the use of placebo. |